cephalosporin c has been researched along with cefixime in 187 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 21 (11.23) | 18.7374 |
| 1990's | 104 (55.61) | 18.2507 |
| 2000's | 33 (17.65) | 29.6817 |
| 2010's | 19 (10.16) | 24.3611 |
| 2020's | 10 (5.35) | 2.80 |
| Authors | Studies |
|---|---|
| Johnson, DM; Jones, RN | 2 |
| Allen, SD; Erwin, ME; Gerlach, EH; Jones, RN; Koontz, FP; Murray, PR; Pfaller, MA; Washington, JA | 2 |
| Fah, YS; Powell, M; Seymour, A; Williams, JD; Yuan, M | 1 |
| Hatakeyama, K; Hori, M; Nakano, K; Sakaguchi, N; Sugita, M; Toyonaga, Y; Yamazaki, M; Yamori, K | 1 |
| Arguedas, AG; Stutman, HR | 1 |
| D'Amico, G; Maccarrone, G; Nicoletti, G; Pellegrino, MB; Privitera, A; Privitera, O; Russo, G; Stefani, S | 1 |
| Iseki, K; Miyazaki, K; Sugawara, M | 1 |
| Iseki, K; Kondo, Y; Miyazaki, K; Shiroto, H; Sugawara, M; Uchino, J | 1 |
| Doyle, WJ; Pinero, BP; Rosenfeld, RM; Seroky, J; Swarts, JD | 1 |
| Clausen, CR; Del Beccaro, MA; Duncan, NO; Inglis, AF; Mendelman, PM; Richardson, MA; Stull, TL | 1 |
| Chaine, G; Mezzanotte, F; Oliary, J; Petitjean, O; Tod, B; Tod, M | 1 |
| Grimm, H | 1 |
| Brumfitt, W; Hamilton-Miller, JM | 1 |
| Flanagan, C; Nash, DR; Steele, LC; Wallace, RJ | 1 |
| Kim, H; Kim, WJ; Ko, KY; Oh, J | 1 |
| Kees, F; Naber, KG | 1 |
| Bauernfeind, A; Jungwirth, R; Schweighart, S; Theopold, M | 1 |
| Gudipati, S; Midkiff, BR; Westblom, TU | 1 |
| Hiraoka, M; Inoue, M; Matsui, H; Mitsuhashi, S | 1 |
| Fukasawa, M; Mutoh, M; Nagata, H; Nouda, H; Okuda, T; Ueda, S; Yamada, H | 1 |
| Roche, G | 1 |
| Couraud, L; Grellet, J; Roche, G; Saux, MC | 1 |
| Bingen, E; Lambert-Zechovsky, N | 1 |
| Chaffin, DO; Henritzy, LL; Lent, K; Mendelman, PM; Smith, AL; Stull, TL; Wiley, EA | 1 |
| Castellani, P; Della Bruna, C; Rossi, R; Younes, G | 1 |
| Noel, GJ; Teele, DW | 1 |
| Barry, AL; Jones, RN | 1 |
| Hori, R; Inui, K; Kato, M; Maegawa, H; Okano, T; Takano, M | 1 |
| Chin, NX; Neu, HC | 1 |
| Cullmann, W; Dick, W; Opferkuch, W; Stieglitz, M | 1 |
| Asai, H; Itoh, Y; Kawamura, S; Kobayashi, K; Matsunaga, T; Ogino, H; Onishi, S; Sakamoto, Y; Shiraishi, T; Ueda, R | 1 |
| Kin, Y; Tamai, I; Tsuji, A | 1 |
| Ayers, LW; Barry, AL; Fuchs, PC; Gavan, TL; Gerlach, EH; Jones, RN | 1 |
| Faulkner, RD; Hiltke, MF; McAteer, JA; Silber, BM | 1 |
| Neu, HC | 1 |
| Hirose, T; Mine, Y; Sakamoto, H | 1 |
| Bialer, M; Tonelli, AP; Yacobi, A | 1 |
| Chin, NX; Labthavikul, P; Neu, HC | 1 |
| Fujishita, Y; Kaizu, M; Kojo, H; Matsumoto, Y; Shigi, Y | 1 |
| Goto, S; Kamimura, T; Kojo, H; Kuwahara, S; Matsumoto, Y; Mine, Y | 1 |
| Hashimoto, A; Iseki, K; Kobayashi, M; Miyazaki, K; Sugawara, M | 1 |
| Farid, Z; Girgis, NI; Hammad, O; Sultan, Y | 1 |
| Appelbaum, PC; Jacobs, MR; Spangler, SK | 1 |
| Anderson, RL; McKnight, JT; Rodman, DP | 1 |
| Kafetzis, DA | 1 |
| Hamano, S; Nakanishi, M; Tamai, I; Terasaki, T; Tsuji, A | 1 |
| Doern, GV; Gerlach, EH; Hindler, J; Jones, RN; St Amand, R | 1 |
| Garcia Iglesias, MC; Perea, EJ | 1 |
| Bauernfeind, A; Cornaglia, G; Fontana, R; Ligozzi, M; Satta, G | 1 |
| Hashimoto, A; Iseki, K; Kobayashi, M; Miyazaki, K; Sugawara, M; Takahashi, M; Toda, T | 1 |
| Rodriguez, WJ; Wiedermann, BL | 1 |
| Dantzig, AH; Duckworth, DC; Tabas, LB | 1 |
| Bass, JW; Chan, DS; Demers, DM | 1 |
| Inamoto, Y; Kawabata, K; Sakane, K; Takaya, T; Yamanaka, H | 1 |
| Berman, S; Roark, R | 1 |
| Doyle, WJ; Greene, I; Rosenfeld, RM; Seroky, J; Swarts, JD | 1 |
| Kumano, K; Kuroyama, M; Motohashi, S; Murase, S; Tomonaga, F | 1 |
| Hausen, T; Schmitt, J; Weidlich, G | 1 |
| Bégué, P; Boulesteix, J; Dabernat, H; de La Rocque, F; Dubreuil, C; Geslin, P; Mégraud, F; Trinh, A | 1 |
| Adam, D; Hostalek, U; Tröster, K | 1 |
| Low, DE | 1 |
| Liston, TE | 1 |
| Biro, FM; Friedland, LR; Kulick, RM; Patterson, A | 1 |
| Cassetta, MI; Conti, S; Dei, R; Fallani, S; Mazzei, T; Novelli, A | 1 |
| Blandino, G; Nicoletti, G; Speciale, A | 1 |
| Boyter, A; Davey, P; Fegan, PG; Nathwani, D | 1 |
| Lee, YS; Park, H | 1 |
| Dancy, RM; Day, SW; Harris, SC; Wang, WC; Wilimas, JA; Williams, LL | 1 |
| Cappelletty, DM; Rybak, MJ | 1 |
| Dan, M; Hafeli, H; Heifetz, L; Poch, F; Somekh, E; Tanai, A | 1 |
| Kasteridou, N; Mamzoridi, K; Niopas, I; Peonides, A | 1 |
| Itokazu, GS; Karavokiros, KT; Schatz, BS; Taeubel, MA | 1 |
| Amir, J; Eidlitz-Markus, T; Harel, L; Varsano, I | 1 |
| Gooch, WM; Philips, A; Rhoades, R; Rosenberg, R; Schaten, R; Starobin, S | 1 |
| Nakagawa, T; Yamaoka, K; Yasui, H | 1 |
| Ohsawa, R; Okazaki, N; Sata, S; Suzuki, R; Wada, A; Watanabe, H; Watanabe, Y; Yamai, S | 1 |
| Gorby, GL; Phanucharas, JP | 1 |
| Goldstein, FW | 1 |
| Bean, K; Hook, EW; Jones, RB; Maroli, AN; Martin, D; McCormack, WM | 1 |
| Block, SL; Chartrand, SA; Harrison, CJ; Hedrick, JA; Pollack, J; Rodriguez, W; Schwartz, R; Thedinger, B | 1 |
| Bajaksouzian, S; Jacobs, MR | 1 |
| Ghaffarzadeh, K; Rastegar Lari, A; Shamshiri, AR; Validi, N | 1 |
| Billoo, AG; Memon, HI; Memon, IA | 1 |
| Bhutta, ZA; Hussain, R; Mansoorali, N | 1 |
| Bégué, P; Boulesteix, J; Dabernat, H; de La Roque, F; Dubreuil, C; Geslin, P; Megraud, F; Scheimberg, A; Trinh, A | 1 |
| Jabbar, A; Siddique, T | 1 |
| Verbist, L; Verhaegen, J | 1 |
| Fachinelli, H; Kijanczuk, S; Mingrone, H; Salvarezza, CR | 1 |
| Asherov, J; Atzmon, Y; Dan, M; Edelman, A; Hafely, H; Poch, F | 1 |
| Asvanich, K; Fugpholngam, V; Srimuang, S; Tanphaichitra, D | 1 |
| Kessler, A; Nagar, H; Weiss, J | 1 |
| Iqbal, I; Malik, MS; Rabbani, W | 1 |
| Adam, D | 1 |
| Matsumoto, Y | 1 |
| Lorenz, J | 1 |
| de Lalla, F | 1 |
| Hamilton-Miller, J | 1 |
| García-Rodríguez, JA | 1 |
| Ludwig, E | 1 |
| Iqbal, I; Malik, MS; Rabbani, MW | 1 |
| Greenman, J; Hassan, IJ; Millar, MR; Stark, RM | 1 |
| Almela, M; García San Miguel, J; Marco, F; Martínez, JA; Mensa, J; Moreno-Martínez, A; Soriano, E; Vila, J | 1 |
| Nikoskelainen, J; Oksi, J; Viljanen, MK | 1 |
| Agbaba, D; Eric-Jovanovic, S; Vladimirov, S; Zivanov-Stakic, D | 1 |
| Basly, I; Basly, JP; Bernard, M | 1 |
| Cao, XT; Kneen, R; Nguyen, TA; Parry, CM; Truong, DL; White, NJ | 1 |
| Elía, S; Ferrer Ruscalleda, F; García Rodríguez, JA; García Sánchez, E | 1 |
| Arcidiacono, MM; Demartini, G; Dugnani, S; Fraschini, F; Pintucci, JP; Scaglione, F | 1 |
| Baskin, M; Charron, M; Hickey, RW; Hoberman, A; Janosky, JE; Kearney, DH; Majd, M; Reynolds, EA; Ruley, J; Wald, ER | 1 |
| Hao, F; Li, J; Zhao, C | 1 |
| Hu, YQ; Qian, CQ; Tan, RX; Yu, WH; Zheng, LY | 1 |
| Chiu, CH; Lin, TY; Ou, JT | 1 |
| Enrique, E; Gaig, P; García-Ortega, P; San Miguel, MM | 1 |
| Burke, JF; Gaughan, WJ; Hassan, MH; McCue, PA; Sharma, K | 1 |
| Albayrak, D; Gök, F; Işlek, I; Küçüködük, S | 1 |
| Geslin, P; Leblanc, F; Petitpretz, P; Rio, Y; Zuck, P | 1 |
| Angelilli, ML; Matsui, DM; Rieder, MJ; Toscani, M | 1 |
| Barash, JR; Janda, JM; Sandfort, RF; Wong, JD | 1 |
| Beach, ML; Biedenbach, DJ; Johnson, DM; Jones, RN; Pfaller, MA | 1 |
| Armada, AA; Casimir, L; De Martino, MG; Debbag, R; Fernandez, C; Paganini, HR; Rodriguez-Brieshcke, MT; Sarkis, CM; Zubizarreta, PA | 1 |
| Maffei, F; Martin, JM; Pitetti, R; Smail, K; Tritt, J; Wald, ER | 1 |
| Ogle, JW | 1 |
| Newton, W; Reed, K | 1 |
| Herrera Benavente, I; Mateos García, E; Medina Santillán, R; Reyes García, G | 1 |
| Baker, DK; Flynn, PM; Hetherington, SV; Hudson, MM; Hughes, WT; Patrick, CC; Roberson, PK; Sandlund, JT; Santana, VM; Shenep, JL; Sixbey, JW; Slobod, KS | 1 |
| Hashido, H; Ishigo, S; Iwata, I; Matsubara, S; Matsukawa, Y; Mikamo, H; Sawamura, H; Suematsu, H; Tamaya, T | 1 |
| Armada, A; Cáceres, E; Casimir, L; Debbag, R; Fernández, C; Firpo, V; Latella, A; Paganini, H; Rodriguez-Brieshcke, T; Zubizarreta, P | 1 |
| Aplasca De Los Reyes, MR; Dallabetta, G; Holmes, KK; Klausner, JD; Manalastas, R; Pato-Mesola, V; Tuazon, CU; Whittington, WL; Wi, T | 1 |
| Cataldi, L; Fanos, V | 1 |
| Blanc, JL; Cheynet, F; Chossegros, C; Ferrara, JJ; Richard, O | 1 |
| Hara-Kudo, Y; Ikedo, M; Komatsu, O; Kumagai, S; Yamamoto, S | 1 |
| Ambrose, PG; Nicolau, DP; Nightingale, CH; Owens, RC; Quintiliani, R; Tessier, P | 1 |
| Hamilton-Miller, JM | 1 |
| Ikeda, F; Ikemoto, A; Matsumoto, K; Matsumoto, Y; Tawara, S; Wakai, Y | 1 |
| Mayfield, JA; Ramus, RM; Sheffield, JS; Wendel, GD | 1 |
| Fung, CP; Ho, MW; Liu, CY; Wang, FD | 1 |
| Greenberg, D; Hoberman, A; Wald, ER | 1 |
| Collvinent, B; Horcajada, JP; Marco, F; Mensa, J; Millá, J; Miró, O; Moreno, A; Sanchez, M | 1 |
| Amores, R; Calvo, A; Prieto, J; Sevillano, D; Valero, E | 1 |
| Aikawa, K; Fujisawa, T; Sata, S; Shimada, T; Takahashi, T; Yamai, S | 1 |
| Berlinghieri, MC; Focà, A; Liberto, MC; Molica, S; Muleo, G | 1 |
| Kobayashi, D; Kuruma, K; Nozawa, T; Tamai, I; Toyobuku, H; Tsuji, A | 1 |
| Hashimoto, T; Kagayama, A; Niwa, T; Shiraga, T | 1 |
| Fabius, GT; Jeronimus, A; Niël-Weise, B | 1 |
| Capparelli, FJ; Del Castillo, ME; Diaz, MF; Hlavnika, A; Leiguarda, R; Wainsztein, NA | 1 |
| Fernandez-Torre, JL | 1 |
| Arakawa, S; Deguchi, T; Egashira, T; Fujime, M; Fujita, K; Fukuhara, Y; Furuya, N; Hirakata, Y; Hirose, T; Igari, J; Imafuku, Y; Ishibashi, K; Ishihara, S; Kamidono, S; Kitamura, M; Kobayashi, Y; Kohno, S; Kondo, A; Konishi, T; Kumamoto, Y; Kumon, H; Kunishima, Y; Matsuda, J; Matsuda, S; Matsukawa, M; Matsumoto, T; Monden, K; Murai, M; Muratani, T; Naito, S; Nakano, M; Oguri, T; Oka, T; Ooe, H; Sato, S; Shigeta, S; Suzutani, T; Tsukamoto, T; Uchida, H; Watanabe, K; Yamaguchi, K; Yamaguti, O; Yoshida, H | 1 |
| Ida, T; Osaki, Y; Senju, N; Takahata, S; Yoshida, T | 1 |
| Bröcker, EB; Gross, GE; Seitz, CS; Trautmann, A; Trcka, J | 1 |
| Tapsall, JW | 1 |
| Barry, PM; Klausner, JD; Liska, S; Pandori, M; Ren, A; Whittington, WL; Wu, A | 1 |
| Beksaç, MS; Katlan, D; Kir, S; Nemutlu, E | 1 |
| Ojani, R; Raoof, JB; Zamani, S | 1 |
| Anisimov, BI; Moldavan, IA; Ryzhko, IV; Shcherbaniuk, AI; Trishina, AV; Tsuraeva, RI | 1 |
| Davies, C; Nicholas, RA; Tomberg, J; Unemo, M | 1 |
| Allen, VG; Farrell, DJ; Lo, S; Low, DE; Melano, RG; Perusini, SJ; Rebbapragada, A; Tan, J; Tijet, N; Towns, L | 1 |
| Hogan, T; Kahlmeter, J; Lam, A; Limnios, A; Ray, S; Tapsall, J; Unemo, M | 1 |
| Ahmad, L; Iqbal, Z; Javed, K; Khan, A; Khan, MI; Nasir, F; Shah, Y | 1 |
| Hashimoto, J; Hiyama, Y; Iwasawa, A; Kurimura, Y; Nishimura, M; Sunaoshi, K; Suzuki, N; Takahashi, S; Takeda, K; Tsukamoto, T; Uehara, T | 1 |
| Adelson, ME; Balashov, S; Gygax, SE; Mordechai, E | 1 |
| Li, QM; Shen, JL; Zhang, M; Zhu, SY | 1 |
| Drews, SJ; Gratrix, J; Lovgren, M; Martin, I; Read, R; Romanowski, B; Singh, AE; Sutherland, K; Talbot, J | 1 |
| de Melo Oliveira, MD; Hauser, P; Kovari, H; Läuchli, S; Meyer, J; Weber, R; Zbinden, R | 1 |
| Endimiani, A; Furrer, H; Guilarte, YN; Hauser, C; Hirzberger, L; Lupo, A; Selvini, S; Tinguely, R | 1 |
| Barbee, LA | 1 |
| Chisholm, SA; Cole, MJ; Hoffmann, S; Ison, CA; Spiteri, G; Unemo, M; Van de Laar, M | 1 |
| Cao, J; Chui, D; Huang, H; Wang, H; Xiao, S | 1 |
| Antonetti, R; Carannante, A; Cusini, M; Ghisetti, V; Latino, MA; Leli, C; Matteelli, A; Ober, P; Poletti, F; Prignano, G; Stefanelli, P; Vacca, P; Vocale, C | 1 |
| Cole, K; Cole, MJ; Cresswell, F; Crook, DW; Dave, J; De Silva, D; Dean, G; Didelot, X; Eyre, DW; Foster, K; Grad, YH; Paul, J; Peters, J; Peto, TE; Thomas, DR; Waldram, A; Walker, AS; Wilson, DJ | 1 |
| Barbee, LA; Blumer, JL; Golden, MR; Gray, W; Griffiss, JM; Nayak, SU; OʼRiordan, MA; Zenilman, JM | 1 |
| Davies, C; Nicholas, RA; Singh, A; Tomberg, J | 1 |
| Deng, X; Klausner, JD | 1 |
| Chen, S; Feng, L; Tan, B; Tao, B; Tian, W; Xiang, B; Zhang, S | 1 |
| Khalim, W; Mwesigye, J; Tungotyo, M; Twinomujuni, SS | 1 |
| Cai, C; Cao, W; Chen, H; Guo, C; Li, M; Liao, Y; Lin, X; Liu, X; Pei, J; Qin, X; Tang, S; Wang, F; Wu, S; Wu, X; Wu, Z; Xie, Q; Yu, Y; Zheng, H | 1 |
| Abu-Raideh, J; Al-Tamimi, M; Albalawi, H; Alhaj, F; Khasawneh, AI; Shalabi, M | 1 |
| Shi, CY; Wang, JF; Ying, HZ | 1 |
| Fazaludeen Koya, S; Galea, S; Hasan Farooqui, H; Mehta, A; Selvaraj, S | 1 |
| Basnyat, B; Darton, TC; Eyre, D; Kuehn, R; Parry, CM; Stoesser, N | 1 |
| Feng, Z; Li, X; Liao, Y; Liu, M; Pan, Y; Qin, X; Wu, X; Xie, Q; Yang, J; Yin, X; Zeng, L; Zheng, H | 1 |
| Ajmal, M; Alqahtani, F; Aziz, M; Imran, I; Majeed, A; Rasool, MF; Rehman, AU; Saeed, H; Zamir, A | 1 |
13 review(s) available for cephalosporin c and cefixime
| Article | Year |
|---|---|
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
[Pulmonary diffusion of cefixime in man].
Topics: Cefixime; Cefotaxime; Cephalosporins; Female; Humans; Lung; Lung Neoplasms; Male; Premedication | 1989 |
A critical review of the new oral cephalosporins. Considerations and place in therapy.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Humans | 1994 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
The role of newer oral cephalosporins, fluoroquinolones, and macrolides in the treatment of pediatric infections.
Topics: Administration, Oral; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Child; Clarithromycin; Fluoroquinolones; Humans | 1994 |
[Research and development of new oral cephems, cefixime and cefdinir].
Topics: Administration, Oral; Animals; Anti-Bacterial Agents; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Structure-Activity Relationship | 1993 |
Management of otitis media. A review.
Topics: Amoxicillin; Anti-Bacterial Agents; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Child; Humans; Otitis Media; Penicillins; Treatment Outcome; Trimethoprim, Sulfamethoxazole Drug Combination | 1995 |
Comparison of cefprozil, cefpodoxime proxetil, loracarbef, cefixime, and ceftibuten.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Cefprozil; Ceftibuten; Ceftizoxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Prodrugs; Randomized Controlled Trials as Topic | 1996 |
Cefixime in urinary tract infections with special reference to pediatrics: overview.
Topics: Bacterial Infections; Cefixime; Cephalosporins; Child; Child, Preschool; Humans; Infant; Urinary Tract Infections | 2001 |
Overview of cefixime use in community-acquired infections.
Topics: Cefixime; Cephalosporins; Community-Acquired Infections; Escherichia coli Infections; Female; Haemophilus Infections; Humans; Male; Neisseriaceae Infections; Patient Compliance; Respiratory Tract Infections; Staphylococcal Infections; Streptococcal Infections; Urinary Tract Infections | 2000 |
Preparing for an era of untreatable gonorrhea.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Drug Administration Schedule; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pharynx; Population Surveillance; Practice Guidelines as Topic; Public Health; Treatment Failure | 2014 |
Treatment of enteric fever (typhoid and paratyphoid fever) with cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Anti-Infective Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Chloramphenicol; Ciprofloxacin; Fluoroquinolones; Humans; Monobactams; Ofloxacin; Pakistan; Paratyphoid Fever; Recurrence; Typhoid Fever | 2022 |
Clinical pharmacokinetics of cefixime: a systematic review.
Topics: Anti-Bacterial Agents; Biological Availability; Cefixime; Cefotaxime; Cephalosporins; Humans | 2023 |
48 trial(s) available for cephalosporin c and cefixime
| Article | Year |
|---|---|
[Bacteriological, pharmacokinetic and clinical studies of 5% and 10% granules of cefdinir in the pediatric field].
Topics: Adolescent; Amoxicillin; Anti-Bacterial Agents; Bacteria; Bacterial Infections; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Dose-Response Relationship, Drug; Female; Humans; Infant; Male; Microbial Sensitivity Tests | 1992 |
Comparison of cefprozil with other antibiotic regimens in the treatment of children with acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Infective Agents; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Otitis Media with Effusion | 1992 |
Bacteriology of acute otitis media: a new perspective.
Topics: Acute Disease; Adolescent; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Bacteriological Techniques; Cefixime; Cefotaxime; Cefpodoxime Proxetil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Haemophilus influenzae; Humans; Infant; Moraxella catarrhalis; Otitis Media; Prodrugs; Punctures; Recurrence; Single-Blind Method; Streptococcus pneumoniae; Tympanic Membrane | 1992 |
Antimicrobial activity of RU29246 (HR916 metabolite) compared with four other oral beta-lactams tested against more than 5000 clinical isolates.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefaclor; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Clavulanic Acids; Drug Therapy, Combination; Enterococcus; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Staphylococcus; Streptococcus agalactiae | 1991 |
[Cefixime, the first oral third-generation cephalosporin].
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Clinical Trials as Topic; Double-Blind Method; Gram-Negative Bacteria; Humans; Prodrugs; Random Allocation | 1989 |
[A parallel comparative double blind study of cefixime with cefroxadine in the treatment of acute lacunar tonsillitis].
Topics: Acute Disease; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Clinical Trials as Topic; Double-Blind Method; Humans; Tonsillitis | 1987 |
Comparison of the efficacy, safety and cost of cefixime, ceftriaxone and aztreonam in the treatment of multidrug-resistant Salmonella typhi septicemia in children.
Topics: Adolescent; Anti-Bacterial Agents; Aztreonam; Bacteremia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cost-Benefit Analysis; Drug Resistance, Multiple; Egypt; Female; Humans; Male; Monobactams; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1995 |
Multi-investigator evaluation of the efficacy and safety of cefprozil, amoxicillin-clavulanate, cefixime and cefaclor in the treatment of acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Bacterial Infections; Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Microbial Sensitivity Tests; Multicenter Studies as Topic; Otitis Media; Randomized Controlled Trials as Topic | 1994 |
Antimicrobial drug suspensions: a blinded comparison of taste of twelve common pediatric drugs including cefixime, cefpodoxime, cefprozil and loracarbef.
Topics: Analysis of Variance; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefotaxime; Cefpodoxime; Cefprozil; Ceftizoxime; Cephalosporins; Child; Child, Preschool; Drug Combinations; Humans; Infant; Single-Blind Method; Smell; Suspensions; Taste | 1994 |
Factors influencing outcome in children treated with antibiotics for acute otitis media.
Topics: Acute Disease; Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clinical Trials as Topic; Female; Follow-Up Studies; Humans; Infant; Male; Otitis Media; Regression Analysis; Risk Factors; Treatment Outcome | 1993 |
Acute otitis media in children: a study of nasopharyngeal carriage of potential pathogens and therapeutic efficacy of cefixime and amoxicillin-clavulanate.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Bacteria; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Humans; Infant; Nasopharynx; Otitis Media | 1995 |
5-day cefixime therapy for bacterial pharyngitis and/or tonsillitis: comparison with 10-day penicillin V therapy. Cefixime Study Group.
Topics: Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Female; Humans; Infant; Male; Penicillin V; Penicillins; Pharyngitis; Streptococcal Infections; Tonsillitis | 1995 |
Betalactam therapy and intestinal flora.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacteria, Anaerobic; Bronchitis; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cephalosporins; Chronic Disease; Clostridium; Enterobacteriaceae; Enterococcus; Feces; HeLa Cells; Humans; Intestines; Microbial Sensitivity Tests; Middle Aged | 1995 |
Outpatient therapy with ceftriaxone and oral cefixime for selected febrile children with sickle cell disease.
Topics: Administration, Oral; Adolescent; Anemia, Sickle Cell; Anti-Infective Agents; Bacteremia; Bacterial Infections; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Drug Therapy, Combination; Female; Fever; Humans; Infant; Male; Outpatients; Patient Compliance | 1996 |
Pharmacokinetics of cefixime in children with urinary tract infections after a single oral dose.
Topics: Adolescent; Adult; Area Under Curve; Cefixime; Cefotaxime; Cephalosporins; Child; Chromatography, High Pressure Liquid; Female; Half-Life; Humans; Male; Urinary Tract Infections | 1996 |
Comparative evaluation of cefixime versus amoxicillin-clavulanate following ceftriaxone therapy of pneumonia.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Penicillins; Pneumonia, Pneumococcal; Radiography | 1996 |
Comparison of the efficacy, safety and acceptability of cefixime and amoxicillin/clavulanate in acute otitis media.
Topics: Acute Disease; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Clavulanic Acids; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Prospective Studies; Treatment Outcome | 1997 |
Comparison of single-dose oral grepafloxacin with cefixime for treatment of uncomplicated gonorrhea in men. The STD Study Group.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; beta-Lactam Resistance; Cefixime; Cefotaxime; Cephalosporins; Fluoroquinolones; Gonorrhea; Humans; Male; Neisseria gonorrhoeae; Penicillin Resistance; Piperazines; Quinolones | 1997 |
Cefixime: an oral option for the treatment of multidrug-resistant enteric fever in children.
Topics: Administration, Oral; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Cost-Benefit Analysis; Drug Resistance, Multiple; Female; Humans; Male; Prospective Studies; Salmonella typhi; Treatment Outcome; Typhoid Fever | 1997 |
Plasma cytokines in paediatric typhoidal salmonellosis: correlation with clinical course and outcome.
Topics: Adolescent; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Cohort Studies; Drug Resistance, Multiple; Enzyme-Linked Immunosorbent Assay; Female; Humans; Infant; Interleukin-6; Male; Morbidity; Salmonella typhi; Severity of Illness Index; Treatment Outcome; Tumor Necrosis Factor-alpha; Typhoid Fever | 1997 |
Effects of cefixime or co-amoxiclav treatment on nasopharyngeal carriage of Streptococcus pneumoniae and Haemophilus influenzae in children with acute otitis media.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactam Resistance; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Female; Haemophilus influenzae; Humans; Infant; Male; Microbial Sensitivity Tests; Nasopharynx; Otitis Media; Streptococcus pneumoniae; Treatment Outcome | 1998 |
Comparison of roxithromycin with cefixime in the treatment of adults with community-acquired pneumonia.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired Infections; Female; Humans; Male; Middle Aged; Pneumonia, Bacterial; Pneumonia, Pneumococcal; Roxithromycin; Streptococcus pneumoniae | 1998 |
Serum bactericidal activity of newer oral cephalosporins in healthy volunteers.
Topics: Administration, Oral; Adolescent; Adult; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cephalosporins; Cross-Over Studies; Female; Haemophilus influenzae; Humans; Klebsiella pneumoniae; Male; Serum Bactericidal Test; Streptococcus | 1998 |
A comparative study of cefixime and chloramphenicol in children with typhoid fever.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Female; Humans; Infant; Male; Treatment Outcome; Typhoid Fever | 1998 |
Comparison of 5-day and 10-day cefixime in the treatment of acute exacerbation of chronic bronchitis.
Topics: Administration, Oral; Bronchitis; Cefixime; Cefotaxime; Cephalosporins; Chronic Disease; Cost-Benefit Analysis; Drug Administration Schedule; Drug Costs; Humans | 1998 |
Cefixime in the treatment of respiratory and urinary tract infections.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child; Humans; Otitis Media; Pneumococcal Infections; Respiratory Tract Infections; Treatment Outcome; Urinary Tract Infections | 1998 |
A comparative study of cefixime and chloramphenicol in children with typhoid fever.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Chloramphenicol; Female; Humans; Male; Remission Induction; Safety; Time Factors; Typhoid Fever | 1998 |
[Cefixime versus amoxicillin plus netilmicin in the treatment of community-acquired non-complicated acute pyelonephritis].
Topics: Acute Disease; Adult; Aged; Amoxicillin; Bacteremia; Cefixime; Cefotaxime; Cephalosporins; Communicable Diseases; Drug Therapy, Combination; Female; Humans; Male; Middle Aged; Netilmicin; Pyelonephritis | 1998 |
Comparison of oral cefixime and intravenous ceftriaxone followed by oral amoxicillin in disseminated Lyme borreliosis.
Topics: Administration, Oral; Adult; Amoxicillin; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Drug Administration Schedule; Drug Therapy, Combination; Humans; Injections, Intravenous; Lyme Disease; Penicillins; Probenecid; Renal Agents; Treatment Outcome | 1998 |
A comparative study of ofloxacin and cefixime for treatment of typhoid fever in children. The Dong Nai Pediatric Center Typhoid Study Group.
Topics: Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Child, Preschool; Drug Resistance, Multiple; Female; Humans; Male; Ofloxacin; Typhoid Fever | 1999 |
Interpretation of middle ear fluid concentrations of antibiotics: comparison between ceftibuten, cefixime and azithromycin.
Topics: Acute Disease; Administration, Oral; Adolescent; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Child; Exudates and Transudates; Female; Humans; Male; Otitis Media with Effusion; Time Factors | 1999 |
Oral versus initial intravenous therapy for urinary tract infections in young febrile children.
Topics: Acute Disease; Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Female; Humans; Infant; Infusions, Intravenous; Logistic Models; Male; Patient Compliance; Pyelonephritis; Recurrence; Urinary Tract Infections | 1999 |
[A randomized controlled clinical study of cefetamet pivoxil versus cefixime in the treatment of 99 cases bacterial infections].
Topics: Adolescent; Adult; Bacterial Infections; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Escherichia coli; Female; Humans; Klebsiella; Male; Respiratory Tract Infections; Streptococcus pyogenes; Urinary Tract Infections | 1997 |
A clinical trial comparing oral azithromycin, cefixime and no antibiotics in the treatment of acute uncomplicated Salmonella enteritis in children.
Topics: Administration, Oral; Anti-Bacterial Agents; Azithromycin; Cefixime; Cefotaxime; Cephalosporins; Enteritis; Female; Humans; Infant; Male; Prospective Studies; Salmonella Infections | 1999 |
Bacteriological eradication of Streptococcus pneumoniae from patients with acute exacerbations of chronic bronchitis: cefuroxime axetil versus cefixime.
Topics: Adult; Aged; Aged, 80 and over; Bronchitis; Cefixime; Cefuroxime; Cephalosporins; Chronic Disease; Double-Blind Method; Female; Humans; Male; Middle Aged; Pneumococcal Infections; Streptococcus pneumoniae | 1999 |
Oral administration of cefixime to lower risk febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Female; Fever; Humans; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors | 2000 |
Treatment of shigellosis with cefixime: two days vs. five days.
Topics: Cefixime; Cephalosporins; Child, Preschool; Double-Blind Method; Dysentery, Bacillary; Female; Humans; Male; Prospective Studies; Time Factors | 2000 |
Efficacy of cefixime in the therapy of typhoid fever.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Feces; Female; Humans; Male; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 2000 |
Oral cefixime is similar to continued intravenous antibiotics in the empirical treatment of febrile neutropenic children with cancer.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Consumer Product Safety; Female; Fever; Humans; Infant; Injections, Intravenous; Male; Neoplasms; Neutropenia; Treatment Failure | 2001 |
Oral ciprofloxacin in the management of children with cancer with lower risk febrile neutropenia.
Topics: Administration, Oral; Adolescent; Amikacin; Anti-Bacterial Agents; Anti-Infective Agents; Antineoplastic Agents; Cefixime; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Female; Fever; Fever of Unknown Origin; Humans; Infant; Infusions, Intravenous; Male; Neoplasms; Neutropenia; Risk Factors; Treatment Outcome | 2001 |
A randomized trial of ciprofloxacin versus cefixime for treatment of gonorrhea after rapid emergence of gonococcal ciprofloxacin resistance in The Philippines.
Topics: Adolescent; Adult; Anti-Infective Agents; Cefixime; Cephalosporins; Ciprofloxacin; Drug Resistance, Microbial; Female; Gonorrhea; Humans; Neisseria gonorrhoeae; Philippines; Prospective Studies; Sex Work; Treatment Outcome | 2001 |
Pharmacodynamics of ceftriaxone and cefixime against community-acquired respiratory tract pathogens.
Topics: Administration, Oral; Adult; Blood Bactericidal Activity; Cefixime; Ceftriaxone; Cephalosporins; Community-Acquired Infections; Cross-Over Studies; Female; Haemophilus Infections; Haemophilus influenzae; Humans; Injections, Intramuscular; Injections, Intravenous; Male; Moraxella catarrhalis; Neisseriaceae Infections; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 2001 |
A randomized trial that compared oral cefixime and intramuscular ceftriaxone for the treatment of gonorrhea in pregnancy.
Topics: Administration, Oral; Adolescent; Adult; Anus Diseases; Cefixime; Ceftriaxone; Cephalosporins; Chlamydia Infections; Female; Gonorrhea; Humans; Injections, Intramuscular; Pharyngeal Diseases; Pregnancy; Pregnancy Complications, Infectious; Prospective Studies; Treatment Outcome; Uterine Cervical Diseases | 2001 |
Comparative study of ceftibuten and cefixime in the treatment of complicated urinary tract infections.
Topics: Adult; Aged; Aged, 80 and over; Cefixime; Ceftibuten; Cephalosporins; Enterobacteriaceae; Enterobacteriaceae Infections; Female; Humans; Male; Middle Aged; Treatment Outcome; Urinary Tract Infections | 2001 |
Short term oral cefixime therapy for treatment of bacterial conjunctivitis.
Topics: Acute Disease; Administration, Oral; Administration, Topical; Anti-Bacterial Agents; Bacitracin; Cefixime; Cephalosporins; Child; Child, Preschool; Conjunctivitis, Bacterial; Double-Blind Method; Drug Therapy, Combination; Female; Humans; Infant; Male; Otitis Media; Polymyxins; Treatment Outcome | 2001 |
Short-term effectiveness of ceftriaxone single dose in the initial treatment of acute uncomplicated pyelonephritis in women. A randomised controlled trial.
Topics: Acute Disease; Adult; Cefixime; Ceftriaxone; Cephalosporins; Female; Humans; Middle Aged; Prospective Studies; Pyelonephritis | 2002 |
Aminopenicillin-induced exanthema allows treatment with certain cephalosporins or phenoxymethyl penicillin.
Topics: Adolescent; Adult; Aged; Amoxicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefpodoxime; Ceftizoxime; Cephalosporins; Cross Reactions; Drug Hypersensitivity; Exanthema; Female; Humans; Hypersensitivity, Delayed; Immunoglobulin E; Male; Middle Aged; Penicillin V; Single-Blind Method; Skin Tests; Treatment Outcome | 2007 |
A Phase 1 Pharmacokinetic and Safety Study of Extended-Duration, High-dose Cefixime for Cephalosporin-resistant Neisseria gonorrhoeae in the Pharynx.
Topics: Administration, Oral; Adolescent; Adult; Anti-Bacterial Agents; Cefixime; Cephalosporins; Cohort Studies; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Pharynx; Young Adult | 2018 |
128 other study(ies) available for cephalosporin c and cefixime
| Article | Year |
|---|---|
Antibacterial activity of the investigational oral and parenteral cephalosporin BK-218.
Topics: beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Gram-Negative Bacteria; Gram-Positive Bacteria; Microbial Sensitivity Tests | 1992 |
Cefdinir (FK482), an orally administered cephalosporin in vitro activity comparison against recent clinical isolates from five medical centers and determination of MIC quality control guidelines.
Topics: Anti-Bacterial Agents; Cefaclor; Cefadroxil; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Drug Evaluation, Preclinical; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Cocci; Humans; Microbial Sensitivity Tests | 1992 |
In vitro susceptibility of Haemophilus influenzae to cefaclor, cefixime, cefetamet and loracarbef.
Topics: Ampicillin Resistance; Cefaclor; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Haemophilus influenzae; Microbial Sensitivity Tests; Regression Analysis | 1992 |
In vitro activity of a new broad-spectrum, beta-lactamase-stable oral cephalosporin, cefixime, in comparison with other drugs, against Haemophilus influenzae, Haemophilus parainfluenzae, Moraxella catarrhalis and Streptococcus pneumoniae.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Haemophilus; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Species Specificity; Streptococcus pneumoniae | 1992 |
H+ coupled transport of orally active cephalosporins lacking an alpha-amino group across brush-border membrane vesicles from rat small intestine.
Topics: Animals; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Hydrogen; In Vitro Techniques; Intestine, Small; Male; Membranes; Microvilli; Rats; Rats, Inbred Strains | 1991 |
Transport characteristics of ceftibuten, cefixime and cephalexin across human jejunal brush-border membrane.
Topics: Biological Transport, Active; Cefixime; Cefotaxime; Ceftibuten; Cephalexin; Cephalosporins; Glucose; Humans; Hydrogen; In Vitro Techniques; Jejunum; Microvilli | 1991 |
Third-generation cephalosporins in the treatment of acute pneumococcal otitis media. An animal study.
Topics: Acoustic Impedance Tests; Acute Disease; Ampicillin; Animals; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Chinchilla; Drug Evaluation, Preclinical; Otitis Media with Effusion; Pneumococcal Infections | 1992 |
[Penetration of cefixime in the anterior chamber of the human eye].
Topics: Administration, Oral; Aged; Aged, 80 and over; Anterior Chamber; Anti-Infective Agents, Urinary; Aqueous Humor; Cataract Extraction; Cefixime; Cefotaxime; Cephalosporins; Humans; Middle Aged; Surgical Sponges | 1991 |
In vitro activity and cross resistance studies with cefpodoxime.
Topics: Anti-Infective Agents, Urinary; Bacteria; Cefixime; Cefotaxime; Cefotiam; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Drug Resistance, Microbial; Humans; Microbial Sensitivity Tests | 1991 |
Comparative in vitro activity of cefixime, cefaclor and loracarbef against urinary pathogens.
Topics: Anti-Infective Agents, Urinary; Bacteria; Cefaclor; Cefixime; Cefotaxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Urinary Tract Infections | 1991 |
Comparison of the activity of cefixime and activities of other oral antibiotics against adult clinical isolates of Moraxella (Branhamella) catarrhalis containing BRO-1 and BRO-2 and Haemophilus influenzae.
Topics: Administration, Oral; Adult; Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acids; Dose-Response Relationship, Drug; Drug Therapy, Combination; Erythromycin; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Tetracycline | 1991 |
Synthesis and biological activity of novel 3-(2-propenyl)-cephalosporins. I.
Topics: Absorption; Administration, Oral; Alkenes; Animals; Bacteria; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Chromatography; Drug Evaluation, Preclinical; Kinetics; Mice; Microbial Sensitivity Tests; Molecular Structure; Rats | 1991 |
[Pharmacokinetics of cefixime in volunteers and a literature comparison with the new ester prodrug cephalosporins].
Topics: Administration, Oral; Adult; Anti-Infective Agents; Biological Availability; Cefixime; Cefotaxime; Cephalosporins; Esters; Female; Half-Life; Humans; Male; Molecular Structure; Prodrugs; Solutions; Suspensions; Tablets | 1990 |
[Antibacterial activity and beta-lactamase stability of eleven oral cephalosporins].
Topics: Administration, Oral; Anti-Bacterial Agents; Bacteria; beta-Lactamases; Cefixime; Cefotaxime; Cephalosporins; Drug Stability; Molecular Structure | 1990 |
In vitro susceptibility of Helicobacter pylori to the new oral cephalosporins cefpodoxime, ceftibuten and cefixime.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Enterobacteriaceae; Helicobacter pylori; Microbial Sensitivity Tests | 1990 |
Antimicrobial activity and stability to beta-lactamase of BMY-28271, a new oral cephalosporin ester.
Topics: Administration, Oral; Animals; beta-Lactamases; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Kinetics; Male; Mice; Microbial Sensitivity Tests; Staphylococcal Infections | 1990 |
New orally active cephalosporin esters.
Topics: Absorption; Administration, Oral; Animals; Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalosporins; Chemical Phenomena; Chemistry; Esters; Mice; Rats | 1990 |
[Structure-activity relationship of oral cephalosporins].
Topics: Absorption; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Structure-Activity Relationship | 1989 |
In vitro activities and targets of three cephem antibiotics against Haemophilus influenzae.
Topics: Ampicillin; Bacterial Proteins; Carrier Proteins; Cefixime; Cefotaxime; Cephalosporins; Culture Media; Haemophilus influenzae; Hexosyltransferases; Kinetics; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin Resistance; Penicillin-Binding Proteins; Peptidyl Transferases; Phenotype | 1989 |
Activity of FCE 22891 compared with cefuroxime axetil and cefixime in pulmonary and subcutaneous infections in mice.
Topics: Abscess; Animals; Anti-Bacterial Agents; Bacterial Infections; Bacteroides fragilis; Bacteroides Infections; Carbapenems; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Female; Half-Life; Lung Diseases; Mice; Microbial Sensitivity Tests; Pneumonia, Pneumococcal | 1989 |
In vitro activities of selected new and long-acting cephalosporins against Pasteurella multocida.
Topics: Cefaclor; Cefixime; Cefoperazone; Cefotaxime; Ceftriaxone; Cephalosporins; Cephalothin; Cloxacillin; Erythromycin; Humans; Microbial Sensitivity Tests; Moxalactam; Oxacillin; Pasteurella; Penicillin G; Penicillin V | 1986 |
In vitro evaluation of ceftibuten (7432-S, SCH 39720), a novel orally administered cephalosporin.
Topics: Administration, Oral; Cefaclor; Cefixime; Cefotaxime; Ceftibuten; Cefuroxime; Cephalexin; Cephalosporins; Enterobacteriaceae; Haemophilus influenzae; Microbial Sensitivity Tests; Moraxella catarrhalis; Neisseria meningitidis; Streptococcus | 1988 |
H+ coupled transport of p.o. cephalosporins via dipeptide carriers in rabbit intestinal brush-border membranes: difference of transport characteristics between cefixime and cephradine.
Topics: 4-Acetamido-4'-isothiocyanatostilbene-2,2'-disulfonic Acid; 4,4'-Diisothiocyanostilbene-2,2'-Disulfonic Acid; Administration, Oral; Animals; Biological Transport; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Dipeptides; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Mucosa; Male; Microvilli; Rabbits; Structure-Activity Relationship | 1988 |
In vitro activity of an oral iminomethoxy aminothiazolyl cephalosporin, R-3746.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactamases; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalexin; Cephalosporins; Clavulanic Acids; Culture Media; Drug Combinations; Drug Stability; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Microbial Sensitivity Tests; Sulfamethoxazole; Trimethoprim; Trimethoprim, Sulfamethoxazole Drug Combination | 1988 |
Comparable evaluation of orally active beta-lactam compounds in ampicillin-resistant gram-positive and gram-negative rods: role of beta-lactamases on resistance.
Topics: Ampicillin Resistance; Anti-Bacterial Agents; beta-Lactamases; Cefixime; Cefotaxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Enterobacteriaceae; Gram-Negative Bacteria; Gram-Positive Bacteria; Plasmids | 1988 |
Carrier-mediated transport of cefixime, a new cephalosporin antibiotic, via an organic anion transport system in the rat renal brush-border membrane.
Topics: Animals; Biological Transport, Active; Cefixime; Cefotaxime; Cephalosporins; Hydrogen-Ion Concentration; Kidney; Male; Microvilli; Potassium; Rats; Rats, Inbred Strains; Valinomycin | 1988 |
Antimicrobial activity of Ro 19-5247 (T-2525), a new oral cephalosporin, tested against 7,745 recent clinical isolates.
Topics: Bacteria; Cefixime; Cefmenoxime; Cefotaxime; Cephalexin; Cephaloridine; Cephalosporins; Enterobacteriaceae; Microbial Sensitivity Tests | 1987 |
Liquid-chromatographic determination of five orally active cephalosporins--cefixime, cefaclor, cefadroxil, cephalexin, and cephradine--in human serum.
Topics: Cefaclor; Cefadroxil; Cefixime; Cefotaxime; Cephalexin; Cephalosporins; Cephradine; Chromatography, High Pressure Liquid; Humans; Reference Standards; Reference Values | 1987 |
In vitro activity of a new broad spectrum, beta-lactamase-stable oral cephalosporin, cefixime.
Topics: Bacteria; Cefixime; Cefotaxime; Cephalosporins; Enterobacteriaceae; Gram-Negative Aerobic Bacteria; Gram-Positive Bacteria | 1987 |
Pharmacokinetics of FK027 in rats and dogs.
Topics: Animals; Bile; Blood Proteins; Cefixime; Cephalosporins; Dogs; Half-Life; Kinetics; Male; Protein Binding; Rats; Rats, Inbred Strains; Species Specificity; Tissue Distribution | 1985 |
Relationship between protein binding and renal clearance of a new oral cephalosporin in the dog.
Topics: Animals; Cefixime; Cefotaxime; Cephalosporins; Dogs; Kidney; Kinetics; Protein Binding | 1985 |
Comparative in vitro activity and beta-lactamase stability of FR 17027, a new orally active cephalosporin.
Topics: Amoxicillin; Bacteria; Bacteria, Anaerobic; beta-Lactamases; Cefixime; Cephalosporins; Humans; Hydrolysis; Microbial Sensitivity Tests | 1984 |
Mechanism of action of the new orally active cephalosporin FK027.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacterial Proteins; beta-Lactamases; Carrier Proteins; Cefaclor; Cefixime; Cephalexin; Cephalosporins; Enterobacter; Escherichia coli; Hexosyltransferases; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases; Staphylococcus aureus | 1984 |
In vitro and in vivo antibacterial properties of FK 027, a new orally active cephem antibiotic.
Topics: Amoxicillin; Animals; Bacteria; Bacteria, Aerobic; Bacteria, Anaerobic; Bacterial Infections; Cefaclor; Cefixime; Cephalexin; Cephalosporins; Mice; Penicillin Resistance | 1984 |
Effect of membrane surface potential on the uptake of anionic compounds by liposomes.
Topics: Anions; Cefixime; Cefotaxime; Ceftibuten; Cell Membrane Permeability; Cephalosporins; Hydroxyindoleacetic Acid; Liposomes; Membrane Potentials; Phosphatidylserines | 1994 |
In vitro susceptibilities of 185 penicillin-susceptible and -resistant pneumococci to WY-49605 (SUN/SY 5555), a new oral penem, compared with those to penicillin G, amoxicillin, amoxicillin-clavulanate, cefixime, cefaclor, cefpodoxime, cefuroxime, and cef
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Carbapenems; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Microbial Sensitivity Tests; Penicillin G; Penicillin Resistance | 1994 |
Intestinal brush-border transport of the oral cephalosporin antibiotic, cefdinir, mediated by dipeptide and monocarboxylic acid transport systems in rabbits.
Topics: Acetates; Animals; Biological Transport, Active; Carboxylic Acids; Cefdinir; Cefixime; Cefotaxime; Cephalosporins; Cephradine; Dipeptides; Hydrogen-Ion Concentration; In Vitro Techniques; Intestinal Absorption; Intestine, Small; Male; Membrane Potentials; Microvilli; Rabbits | 1993 |
Revised disk diffusion interpretive criteria for cefaclor, loracarbef, cefprozil and cefixime when testing Haemophilus influenzae on haemophilus test medium.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Culture Media; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Quality Control | 1994 |
Comparative in-vitro activity of cefdinir against multiresistant Haemophilus influenzae.
Topics: Amoxicillin; Amoxicillin-Potassium Clavulanate Combination; Ampicillin Resistance; beta-Lactamases; Cefaclor; Cefdinir; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Clavulanic Acids; Drug Resistance, Multiple; Haemophilus influenzae; Kinetics; Microbial Sensitivity Tests | 1994 |
PBP binding and periplasmic concentration as determinants of the antibacterial activities of three new oral cephalosporins in Escherichia coli.
Topics: Bacterial Proteins; Biological Transport; Carrier Proteins; Cefixime; Cefotaxime; Ceftizoxime; Cefuroxime; Cell Membrane; Cell Membrane Permeability; Cephalosporins; Dose-Response Relationship, Drug; Escherichia coli; Hexosyltransferases; Microbial Sensitivity Tests; Muramoylpentapeptide Carboxypeptidase; Penicillin-Binding Proteins; Peptidyl Transferases | 1994 |
Changes in the permeation rate of organic anions through the intestinal brush-border membrane with membrane surface potential.
Topics: Anilino Naphthalenesulfonates; Animals; Anions; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Diffusion; Fluorescent Dyes; Hydrogen-Ion Concentration; Intestinal Mucosa; Membrane Potentials; Microvilli; Penicillin G; Permeability; Rats | 1994 |
Transport mechanisms responsible for the absorption of loracarbef, cefixime, and cefuroxime axetil into human intestinal Caco-2 cells.
Topics: Adenocarcinoma; Amino Acids; Biological Transport; Cefixime; Cefotaxime; Cefuroxime; Cephalosporins; Colonic Neoplasms; Dipeptides; Drug Antagonism; Energy Metabolism; Humans; Intestinal Absorption; Tumor Cells, Cultured | 1994 |
Efficacy of ceftibuten for acute otitis media caused by Hemophilus influenzae: an animal study.
Topics: Acute Disease; Ampicillin; Animals; Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Chinchilla; Haemophilus Infections; Haemophilus influenzae; Otitis Media; Random Allocation | 1993 |
[Protein binding of oral cephems in patients with chronic renal failure].
Topics: Carrier Proteins; Cefdinir; Cefixime; Cefotaxime; Ceftibuten; Cephalosporins; Humans; Kidney Failure, Chronic; Palmitic Acid; Palmitic Acids; Renal Dialysis | 1993 |
Safety and efficacy of cefixime in treatment of respiratory tract infections in Germany.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Female; Humans; Male; Respiratory Tract Infections | 1995 |
Assessment of the use of cefixime for switch therapy.
Topics: Administration, Oral; Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Humans; Injections; Patient Compliance | 1995 |
Cost-effectiveness decision analysis of intramuscular ceftriaxone versus oral cefixime in adolescents with gonococcal cervicitis.
Topics: Administration, Oral; Adolescent; Anti-Infective Agents; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Cost of Illness; Cost-Benefit Analysis; Decision Support Techniques; Decision Trees; Female; Gonorrhea; Humans; Injections, Intramuscular; Treatment Outcome; Uterine Cervicitis | 1996 |
Third generation oral cephalosporins: comparative in vitro kinetics.
Topics: Administration, Oral; Cefixime; Cefotaxime; Ceftibuten; Ceftizoxime; Cephalosporins; Escherichia coli; Haemophilus influenzae; Kinetics; Klebsiella pneumoniae; Microbial Sensitivity Tests; Moraxella catarrhalis; Streptococcus pneumoniae; Streptococcus pyogenes | 1995 |
Switch therapy in community-acquired pneumonia.
Topics: Administration, Oral; Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Community-Acquired Infections; Hospitalization; Humans; Infusions, Intravenous; Pneumonia; Treatment Outcome; United Kingdom | 1996 |
Synthesis and biological activity of C-3 direct heterocyclylcarbon-substituted novel cephalosporins.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Microbial Sensitivity Tests; Structure-Activity Relationship; Thiazoles | 1996 |
Bactericidal activities of cefprozil, penicillin, cefaclor, cefixime, and loracarbef against penicillin-susceptible and -resistant Streptococcus pneumoniae in an in vitro pharmacodynamic infection model.
Topics: Cefaclor; Cefixime; Cefotaxime; Cefprozil; Cephalosporins; Colony-Forming Units Assay; Humans; Microbial Sensitivity Tests; Models, Theoretical; Penicillin Resistance; Penicillins; Streptococcus pneumoniae | 1996 |
Penetration and bactericidal activity of cefixime in synovial fluid.
Topics: Adult; Aged; Cefixime; Cefotaxime; Cephalosporins; Escherichia coli; Female; Haemophilus influenzae; Humans; Joint Diseases; Male; Middle Aged; Rheumatic Diseases; Synovial Fluid; Time Factors | 1996 |
Alternative continuous infusion method for analysis of enterohepatic circulation and biliary excretion of cefixime in the rat.
Topics: Animals; Bile; Cefixime; Cefotaxime; Cephalosporins; Enterohepatic Circulation; Male; Rats; Rats, Wistar | 1994 |
[Studies on enrichment broth for verotoxin-producing Escherichia coli (VTEC) O157].
Topics: Aeromonas; Anti-Bacterial Agents; Bacterial Toxins; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Escherichia coli O157; Novobiocin; Pseudomonas; Shiga Toxin 1; Tellurium; Temperature; Vancomycin | 1997 |
Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture.
Topics: Anti-Infective Agents; Cefixime; Cefotaxime; Cephalosporins; Ciprofloxacin; Drug Evaluation, Preclinical; Fallopian Tubes; Female; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Organ Culture Techniques | 1997 |
Choice of an oral beta-lactam antibiotic for infections due to penicillin-resistant Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; beta-Lactam Resistance; Cefaclor; Cefixime; Cefotaxime; Cefpodoxime; Ceftizoxime; Cefuroxime; Cephalosporins; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Pneumococcal Infections; Protein Binding; Streptococcus pneumoniae | 1997 |
[Infections in childhood; from respiratory infections to tropical medicine].
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Child; Dexamethasone; Humans; Meningitis; Otitis Media; Respiratory Tract Infections | 1993 |
Middle ear effusion concentrations of cefixime during acute otitis media with effusion and otitis media with effusion.
Topics: Acute Disease; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Ear, Middle; Humans; Infant; Otitis Media with Effusion | 1997 |
Evaluation of Haemophilus influenzae isolates with elevated MICs to amoxicillin/clavulanic acid.
Topics: Amoxicillin; Anti-Bacterial Agents; Bacteriological Techniques; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Clavulanic Acids; Culture Media; Drug Resistance, Microbial; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Osmolar Concentration; Penicillins | 1997 |
In vitro activity of cefixime versus ceftizoxime against Salmonella typhi.
Topics: Anti-Bacterial Agents; Cefixime; Cefotaxime; Ceftizoxime; Cephalosporins; Drug Resistance, Microbial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Salmonella typhi; Typhoid Fever | 1997 |
A case of pseudolymphoma leukaemia syndrome following cefixime.
Topics: Cefixime; Cefotaxime; Cephalosporins; Diagnosis, Differential; Female; Humans; Leukemia; Middle Aged; Pseudolymphoma; Sezary Syndrome | 1998 |
In-vitro activity of 21 beta-lactam antibiotics against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Topics: Amoxicillin; Ampicillin; Anti-Bacterial Agents; beta-Lactams; Carbapenems; Cefaclor; Cefadroxil; Cefatrizine; Cefepime; Cefixime; Cefotaxime; Cefpirome; Cefpodoxime; Ceftazidime; Ceftibuten; Ceftizoxime; Ceftriaxone; Cefuroxime; Cephalosporins; Cephradine; Drug Resistance, Microbial; Drug Resistance, Multiple; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Piperacillin; Pneumococcal Infections; Serotyping; Species Specificity; Streptococcus pneumoniae | 1998 |
In vitro activity and clinical evaluation of cefixime in urinary tract infection.
Topics: Adult; Aged; Cefixime; Cefotaxime; Cephalosporins; Drug Administration Schedule; Female; Humans; Microbial Sensitivity Tests; Middle Aged; Urinary Tract Infections | 1998 |
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 19-1998. A 70-year-old man with diarrhea, polyarthritis, and a history of Reiter's syndrome.
Topics: Aged; Arthritis; Arthritis, Reactive; Cefixime; Cefotaxime; Cephalosporins; Clostridioides difficile; Diagnosis, Differential; Diarrhea; Enterocolitis, Pseudomembranous; Humans; Male | 1998 |
Combinations of orally administered beta-lactams to maximize spectrum and activity against drug-resistant respiratory tract pathogens: I. Synergy studies of amoxicillin and cefixime with Streptococcus pneumoniae.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Penicillin Resistance; Penicillins; Respiratory System; Streptococcus pneumoniae | 1998 |
Bacterial orchitis in a baby with imperforate anus.
Topics: Anus, Imperforate; Cefixime; Cefotaxime; Cephalosporins; Escherichia coli Infections; Humans; Infant; Male; Orchitis; Recurrence; Ultrasonography, Doppler, Color | 1998 |
Overview of the clinical features of cefixime.
Topics: Bacterial Infections; Cefixime; Cefotaxime; Cephalosporins; Chemistry, Pharmaceutical; Drug Administration Schedule; Humans | 1998 |
Combination cefixime/amoxicillin against penicillin-resistant Streptococcus pneumoniae infection.
Topics: Amoxicillin; Animals; Cefixime; Cefotaxime; Cephalosporins; Drug Synergism; Drug Therapy, Combination; Humans; Mice; Penicillin Resistance; Penicillins; Pneumococcal Infections; Respiratory Tract Infections; Streptococcus pneumoniae | 1998 |
Cefixime in the treatment of upper respiratory tract infections and otitis media.
Topics: Cefixime; Cefotaxime; Cephalosporins; Humans; Otitis Media; Patient Compliance; Penicillin Resistance; Respiratory Tract Infections; Streptococcal Infections; Treatment Outcome | 1998 |
Cefixime for switch therapy.
Topics: Administration, Oral; Cefixime; Cefotaxime; Cephalosporins; Cost-Benefit Analysis; Drug Administration Schedule; Humans; Infusions, Intravenous; Practice Guidelines as Topic; Treatment Outcome | 1998 |
Bacteriological comparison of cefixime in patients with noncomplicated urinary tract infection in Spain. Preliminary results.
Topics: Amoxicillin; Anti-Bacterial Agents; Cefixime; Cefotaxime; Cephalosporins; Clavulanic Acid; Drug Resistance, Microbial; Escherichia coli; Humans; Penicillins; Spain; Urinary Tract Infections | 1998 |
Clinical role of cefixime in community-acquired infections.
Topics: Administration, Oral; Amoxicillin; Cefixime; Cefotaxime; Cephalosporins; Drug Administration Schedule; Drug Resistance, Microbial; Drug Synergism; Drug Therapy, Combination; Humans; Infusions, Intravenous; Treatment Outcome | 1998 |
Absence of a post-antibiotic effect (PAE) of beta-lactams against Helicobacter pylori NCTC 11637.
Topics: Ampicillin; Anti-Bacterial Agents; beta-Lactams; Cefixime; Cefotaxime; Cephalosporins; Colony Count, Microbial; Culture Media; Helicobacter pylori; Microbial Sensitivity Tests; Penicillins | 1998 |
HPTLC determination of ceftriaxone, cefixime and cefotaxime in dosage forms.
Topics: Cefixime; Cefotaxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Dosage Forms; Reproducibility of Results; Sensitivity and Specificity | 1998 |
Radiation induced effects on cephalosporins: an ESR study.
Topics: Cefixime; Cefotaxime; Cefpodoxime; Cefsulodin; Ceftizoxime; Cephalosporins; Electron Spin Resonance Spectroscopy; Free Radicals; Gamma Rays | 1999 |
[Prevalence of urinary infections in the community and their susceptibility to cefixime].
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Cefixime; Cephalosporins; Cross-Sectional Studies; Drug Resistance, Microbial; Female; Humans; Male; Middle Aged; Prevalence; Prospective Studies; Urinary Tract Infections | 1999 |
Intestinal absorption of cefixime in rats.
Topics: Animals; Cefixime; Cephalosporins; Edetic Acid; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Rats | 1999 |
Selective type-1 hypersensitivity to cefixime.
Topics: Adult; Cefixime; Cefotaxime; Cephalosporins; Drug Hypersensitivity; Female; Humans; Urticaria | 1999 |
Association of IgA nephropathy with Clostridium difficile colitis.
Topics: Acute Kidney Injury; Adult; Cefixime; Cefotaxime; Cephalosporins; Clostridioides difficile; Enterocolitis, Pseudomembranous; Female; Glomerulonephritis, IGA; Humans; Kidney | 1999 |
Nephrotic syndrome following cefixime therapy in a 10-month-old girl: spontaneous resolution without corticosteroid treatment.
Topics: Cefixime; Cephalosporins; Female; Humans; Infant; Nephrotic Syndrome; Remission, Spontaneous | 1999 |
Palatability of oral antibiotics among children in an urban primary care center.
Topics: Administration, Oral; Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Cefixime; Cefprozil; Cephalosporins; Child; Child, Preschool; Female; Flavoring Agents; Humans; Male; Pain Measurement; Patient Acceptance of Health Care; Taste; Urban Population | 2000 |
Susceptibilities of Yersinia pestis strains to 12 antimicrobial agents.
Topics: Animals; Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Yersinia pestis | 2000 |
Antimicrobial activity and in vitro susceptibility test development for cefditoren against Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus species.
Topics: Cefaclor; Cefixime; Cephalosporins; Gram-Negative Bacterial Infections; Haemophilus Infections; Haemophilus influenzae; Humans; Microbial Sensitivity Tests; Moraxella catarrhalis; Penicillins; Streptococcal Infections; Streptococcus | 2000 |
Antimicrobial therapy for ambulatory pediatrics.
Topics: Ambulatory Care; Anti-Bacterial Agents; Anti-Infective Agents; Cefixime; Cefuroxime; Cephalexin; Cephalosporins; Child; Fluoroquinolones; Humans; Macrolides; Otitis Media; Penicillins; Pharyngitis; Pneumonia, Bacterial; Sinusitis; Urinary Tract Infections | 1999 |
Oral or IV antibiotics for the treatment of febrile children with UTIs?
Topics: Administration, Oral; Anti-Infective Agents, Urinary; Cefixime; Cefotaxime; Cephalosporins; Child, Preschool; Fever; Humans; Infant; Infusions, Intravenous; Randomized Controlled Trials as Topic; Treatment Outcome; Urinary Tract Infections | 1999 |
[The frequency of Streptococcus pneumoniae strains and sensitivity surveillance for several antibiotics in Gifu Prefecture].
Topics: Amoxicillin; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cefmenoxime; Cefpodoxime; Ceftizoxime; Cephalosporins; Ciprofloxacin; Clarithromycin; Clindamycin; Drug Resistance, Microbial; Fluoroquinolones; Humans; Imipenem; Japan; Levofloxacin; Meropenem; Microbial Sensitivity Tests; Minocycline; Naphthyridines; Ofloxacin; Penicillin G; Penicillins; Streptococcus pneumoniae; Thienamycins | 2000 |
[Infectious complications of mandibular osteotomy].
Topics: Adolescent; Adult; Antibiotic Prophylaxis; Bone Plates; Cefamandole; Cefixime; Cephalosporins; Cutaneous Fistula; Female; Follow-Up Studies; Hematoma; Humans; Lymphadenitis; Male; Mandible; Middle Aged; Oral Hygiene; Osteitis; Osteotomy; Periodontal Diseases; Retrospective Studies; Risk Factors; Smoking; Surgical Wound Infection; Time Factors | 2001 |
[Development of chromogenic agar medium for isolation of enterohaemorrhagic Escherichia coli O26].
Topics: Agar; Cefixime; Cephalosporins; Culture Media; Drug Resistance, Microbial; Escherichia coli; Serotyping | 2001 |
Mechanism of therapeutic effectiveness of cefixime against typhoid fever.
Topics: Animals; Cefixime; Cell Survival; Cephalosporins; Disease Models, Animal; Humans; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Salmonella; Salmonella Infections; Serotyping; Treatment Outcome; Tumor Cells, Cultured; Typhoid Fever | 2001 |
[Activity of different antimicrobial agents against penicillin-resistant Streptococcus pneumoniae].
Topics: Amoxicillin; Anti-Bacterial Agents; Azithromycin; Cefaclor; Cefixime; Cefpodoxime; Ceftibuten; Ceftizoxime; Cefuroxime; Cephalosporins; Clavulanic Acid; Community-Acquired Infections; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Penicillin Resistance; Pneumonia, Pneumococcal; Spain; Streptococcus pneumoniae | 2001 |
Evaluation of sorbitol-salicin MacConkey medium containing cefixime and tellurite (CT-SSMAC medium) for isolation of Escherichia coli O157:H7 from raw vegetables.
Topics: Agar; beta-Galactosidase; Cefixime; Cephalosporins; Colony Count, Microbial; Color; Culture Media; Escherichia coli O157; Tellurium; Vegetables | 2002 |
Cefixime does not affect polymorphonuclear cell and monocyte functions from chronic lymphoid leukemia patients and from healthy donors.
Topics: Administration, Oral; Cefixime; Cephalosporins; Humans; Leukemia, Lymphocytic, Chronic, B-Cell; Monocytes; Neutrophils | 1991 |
Enhanced intestinal absorption of drugs by activation of peptide transporter PEPT1 using proton-releasing polymer.
Topics: Acrylic Resins; Administration, Oral; Animals; Anti-Bacterial Agents; Carrier Proteins; Cefixime; Cephalosporins; Hydrogen-Ion Concentration; Intestinal Absorption; Male; Peptide Transporter 1; Pharmaceutical Preparations; Polymers; Protons; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet; Symporters | 2003 |
Effect of cefixime and cefdinir, oral cephalosporins, on cytochrome P450 activities in human hepatic microsomes.
Topics: Biotransformation; Cefdinir; Cefixime; Cephalosporins; Cytochrome P-450 Enzyme System; Humans; In Vitro Techniques; Isoenzymes; Kinetics; Microsomes, Liver | 2004 |
An epidemiological study of three cephalosporins: cefotetan, cefixime and cefpirome.
Topics: Bacteria; Bacterial Infections; Cefixime; Cefotetan; Cefpirome; Cephalosporins; Humans; Microbial Sensitivity Tests; Regression Analysis | 1989 |
Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Brain; Cefepime; Cefixime; Cephalosporins; Confusion; Consciousness Disorders; Delirium; Epididymitis; Humans; Kidney; Male; Metabolic Clearance Rate; Neurotoxicity Syndromes; Penicillanic Acid; Piperacillin; Recovery of Function; Secondary Prevention; Systemic Inflammatory Response Syndrome; Tazobactam; Urinary Tract Infections; Withholding Treatment | 2005 |
Cefepime- and cefixime-induced encephalopathy in a patient with normal renal function.
Topics: Aged, 80 and over; Anti-Bacterial Agents; Brain; Cefepime; Cefixime; Cephalosporins; Epilepsy, Generalized; Humans; Kidney; Male; Neurotoxicity Syndromes | 2006 |
[Comparative studies on activities of antimicrobial agents against causative organisms isolated from patients with urinary tract infections (2004). I. Susceptibility distribution].
Topics: Aminoglycosides; Ampicillin; Anti-Infective Agents; Aztreonam; Cefixime; Cefozopran; Cefpirome; Cefpodoxime; Ceftizoxime; Cephalosporins; Dibekacin; Drug Resistance, Bacterial; Enterococcus faecalis; Escherichia coli; Gentamicins; Gram-Negative Bacteria; Gram-Positive Bacteria; Humans; Imipenem; Klebsiella pneumoniae; Meropenem; Microbial Sensitivity Tests; Proteus mirabilis; Pseudomonas aeruginosa; Quinolones; Serratia marcescens; Staphylococcus aureus; Thienamycins; Urinary Tract Infections; Vancomycin | 2006 |
Amino acid substitutions in mosaic penicillin-binding protein 2 associated with reduced susceptibility to cefixime in clinical isolates of Neisseria gonorrhoeae.
Topics: Amino Acid Sequence; Amino Acid Substitution; Bacterial Proteins; Cefixime; Cephalosporins; Cloning, Molecular; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Mutagenesis, Site-Directed; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Porins; Recombination, Genetic; Reverse Transcriptase Polymerase Chain Reaction; Transformation, Genetic | 2006 |
Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci.
Topics: Anti-Bacterial Agents; Asia, Southeastern; Australia; Cefixime; Cefotaxime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Dose-Response Relationship, Drug; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Pacific Islands; Treatment Failure; World Health Organization | 2009 |
Mosaic penicillin-binding protein 2 in Neisseria gonorrhoeae isolates collected in 2008 in San Francisco, California.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; California; Cefixime; Cephalosporins; Drug Resistance, Multiple, Bacterial; Molecular Sequence Data; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Homology, Amino Acid | 2009 |
Simultaneous multiresponse optimization of an HPLC method to separate seven cephalosporins in plasma and amniotic fluid: application to validation and quantification of cefepime, cefixime and cefoperazone.
Topics: Amniotic Fluid; Calibration; Cefepime; Cefixime; Cefoperazone; Cefotaxime; Ceftazidime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chromatography, High Pressure Liquid; Drug Stability; Female; Humans; Molecular Structure; Pregnancy; Reproducibility of Results; Temperature | 2009 |
A novel sensor for cephalosporins based on electrocatalytic oxidation by poly(o-anisidine)/SDS/Ni modified carbon paste electrode.
Topics: Aniline Compounds; Biosensing Techniques; Catalysis; Cefixime; Ceftizoxime; Ceftriaxone; Cephalosporins; Chemistry Techniques, Analytical; Electrochemistry; Electrodes; Models, Chemical; Nickel; Oxygen; Sodium Dodecyl Sulfate; Solvents | 2010 |
[Efficacy of cefixime and cefepime vs. other cephalosporins in experimental plague of albino mice due to variants FI+ and FI- of the plague microbe].
Topics: Animals; Anti-Bacterial Agents; Antigens, Bacterial; Bacterial Capsules; Cefepime; Cefixime; Cephalosporins; Dose-Response Relationship, Drug; Mice; Plague; Species Specificity; Yersinia pestis | 2007 |
Molecular and structural analysis of mosaic variants of penicillin-binding protein 2 conferring decreased susceptibility to expanded-spectrum cephalosporins in Neisseria gonorrhoeae: role of epistatic mutations.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Penicillins | 2010 |
Molecular analysis of antimicrobial resistance mechanisms in Neisseria gonorrhoeae isolates from Ontario, Canada.
Topics: Amino Acid Sequence; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Molecular Sequence Data; Neisseria gonorrhoeae; Ontario; Penicillin-Binding Proteins; Polymerase Chain Reaction; Sequence Analysis, DNA | 2011 |
Cefpodoxime 10 μg disc screening test for detection of Neisseria gonorrhoeae with mosaic PBP2 and decreased susceptibility to extended-spectrum cephalosporins for public health purposes.
Topics: Alleles; Anti-Bacterial Agents; Cefixime; Cefpodoxime; Ceftizoxime; Ceftriaxone; Cephalosporins; Dose-Response Relationship, Drug; Drug Resistance, Bacterial; Gonorrhea; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Sequence Analysis, DNA | 2011 |
Cephalosporin susceptibility among Neisseria gonorrhoeae isolates--United States, 2000-2010.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Female; Gonorrhea; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Population Surveillance; United States | 2011 |
Simultaneous determination of cefdinir and cefixime in human plasma by RP-HPLC/UV detection method: Method development, optimization, validation, and its application to a pharmacokinetic study.
Topics: Cefdinir; Cefixime; Cephalosporins; Chromatography, High Pressure Liquid; Chromatography, Reverse-Phase; Humans | 2011 |
Antimicrobial susceptibility and penicillin-binding protein 1 and 2 mutations in Neisseria gonorrhoeae isolated from male urethritis in Sapporo, Japan.
Topics: Anti-Bacterial Agents; Cefixime; Cephalosporin Resistance; Cephalosporins; Gonorrhea; Humans; Japan; Male; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Urethritis | 2013 |
Multiplex bead suspension array for screening Neisseria gonorrhoeae antibiotic resistance genetic determinants in noncultured clinical samples.
Topics: Alleles; Anti-Infective Agents; Azithromycin; Cefixime; Cephalosporins; Chromosomes, Bacterial; Ciprofloxacin; DNA, Bacterial; Drug Resistance, Bacterial; Gene Expression Profiling; High-Throughput Nucleotide Sequencing; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillins; Plasmids; Reproducibility of Results; Sensitivity and Specificity; Sequence Analysis, DNA; Spectinomycin; Tetracycline | 2013 |
[Study on cephalosporins with terahertz time-domain spectroscopy technique].
Topics: Cefixime; Cephalosporins; Refractometry; Terahertz Spectroscopy | 2013 |
Neisseria gonorrhoeae multiantigen sequence typing is beneficial in further characterizing gonococcal populations in Alberta, Canada.
Topics: Alberta; Anti-Bacterial Agents; Antigens, Bacterial; Azithromycin; Bacterial Typing Techniques; Cefixime; Ceftriaxone; Cephalosporins; DNA, Bacterial; Drug Resistance, Bacterial; Female; Gonorrhea; Heterosexuality; Homosexuality, Female; Homosexuality, Male; Humans; Male; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny; Retrospective Studies | 2013 |
Decreased susceptibility of Neisseria gonorrhoeae isolates from Switzerland to Cefixime and Ceftriaxone: antimicrobial susceptibility data from 1990 and 2000 to 2012.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Drug Resistance, Bacterial; Female; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Neisseria gonorrhoeae; Switzerland; Young Adult | 2013 |
Characterization of Neisseria gonorrhoeae isolates detected in Switzerland (1998-2012): emergence of multidrug-resistant clones less susceptible to cephalosporins.
Topics: Adolescent; Adult; Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Child; Child, Preschool; Ciprofloxacin; Drug Resistance, Multiple, Bacterial; Female; Gonorrhea; Humans; Infant; Infant, Newborn; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Penicillins; Phenotype; Switzerland; Tetracycline; Young Adult | 2014 |
Emerging cephalosporin and multidrug-resistant gonorrhoea in Europe.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Ciprofloxacin; Europe; European Union; Gonorrhea; Humans; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Sentinel Surveillance | 2014 |
Mass Spectral Profile for Rapid Differentiating Beta-Lactams from Their Ring-Opened Impurities.
Topics: Anti-Bacterial Agents; beta-Lactams; Cefaclor; Cefdinir; Cefixime; Cephalosporins; Chromatography, High Pressure Liquid; Humans; Mass Spectrometry | 2015 |
Genetic Resistance Determinants for Cefixime and Molecular Analysis of Gonococci Isolated in Italy.
Topics: Alleles; Amino Acid Substitution; Anti-Bacterial Agents; Bacterial Proteins; Cefixime; Ceftriaxone; Cephalosporins; Drug Resistance, Bacterial; Genotype; Gonorrhea; Humans; Italy; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Promoter Regions, Genetic | 2017 |
Whole-genome sequencing to determine transmission of Neisseria gonorrhoeae: an observational study.
Topics: Adult; Alleles; Anti-Bacterial Agents; Cefixime; Cephalosporin Resistance; Cephalosporins; Female; Genotype; Gonorrhea; Humans; Male; Microbial Sensitivity Tests; Neisseria gonorrhoeae; Retrospective Studies; Sequence Analysis, DNA; United Kingdom | 2016 |
Recognition of the β-lactam carboxylate triggers acylation of
Topics: Acylation; Alleles; Binding Sites; Catalytic Domain; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; Gonorrhea; Humans; Microbial Sensitivity Tests; Mutation; Neisseria gonorrhoeae; Penicillin-Binding Proteins; Serine-Type D-Ala-D-Ala Carboxypeptidase | 2019 |
Six penA Codons Accurately and Reliably Predict Cefixime-Decreased Susceptibility in Neisseria gonorrhoeae.
Topics: Azithromycin; Cefixime; Ceftriaxone; Cephalosporins; Codon; Evolution, Molecular; Gonorrhea; Humans; Neisseria gonorrhoeae; United States | 2020 |
Two novel drugs as bio-functional inhibitors for copper performing excellent anticorrosion and antibacterial properties.
Topics: Adsorption; Anti-Bacterial Agents; Cefixime; Cefpirome; Cephalosporins; Copper; Corrosion; Electrons; Escherichia coli; Microbial Sensitivity Tests; Molecular Conformation; Particle Size; Staphylococcus aureus; Steel; Surface Properties | 2020 |
Resistance pattern of infected chronic wound isolates and factors associated with bacterial resistance to third generation cephalosporins at Mbarara Regional Referral Hospital, Uganda.
Topics: Adult; Aged; Anti-Bacterial Agents; Cefixime; Cefoperazone; Cefpodoxime; Ceftizoxime; Cephalosporins; Chronic Disease; Drug Resistance, Bacterial; Female; Hospitals; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Sulbactam; Uganda; Wound Infection | 2021 |
Markedly Increasing Antibiotic Resistance and Dual Treatment of Neisseria gonorrhoeae Isolates in Guangdong, China, from 2013 to 2020.
Topics: Anti-Bacterial Agents; Azithromycin; Cefixime; Ceftriaxone; Cephalosporin Resistance; Cephalosporins; China; Drug Resistance, Bacterial; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae | 2022 |
Cefixime and cefixime-clavulanate for screening and confirmation of extended-spectrum beta-lactamases in Escherichia coli.
Topics: Adolescent; Adult; Aged; beta-Lactamases; Cefixime; Cephalosporins; Clavulanic Acid; Escherichia coli; Escherichia coli Infections; Female; Humans; Male; Microbial Sensitivity Tests; Middle Aged; Young Adult | 2022 |
Cephalosporins-induced intestinal dysbiosis exacerbated pulmonary endothelial barrier disruption in streptococcus pneumoniae-infected mice.
Topics: Animals; Anti-Bacterial Agents; Cefaclor; Cefdinir; Cefixime; Cephalosporins; Dysbiosis; Inflammation; Mice; Streptococcus pneumoniae | 2022 |
Quantifying antibiotic use in typhoid fever in India: a cross-sectional analysis of private sector medical audit data, 2013-2015.
Topics: Anti-Bacterial Agents; Cefixime; Cephalosporins; Child; Cross-Sectional Studies; Drug Prescriptions; Female; Humans; India; Male; Medical Audit; Ofloxacin; Practice Patterns, Physicians'; Private Sector; Quinolones; Typhoid Fever; Young Adult | 2022 |
Dissemination of Neisseria gonorrhoeae with decreased susceptibility to extended-spectrum cephalosporins in Southern China, 2021: a genome-wide surveillance from 20 cities.
Topics: Anti-Bacterial Agents; Cefixime; Ceftriaxone; Cephalosporins; Cities; Gonorrhea; Humans; Microbial Sensitivity Tests; Multilocus Sequence Typing; Neisseria gonorrhoeae; Phylogeny | 2023 |